Form 4: Eli Lilly Executive's Planned Stock Transactions Revealed

An Eli Lilly executive reported the acquisition of common stock from restricted stock units and a subsequent disposition for tax withholding purposes.

Summary

• Edgardo Hernandez, EVP & President of Manufacturing Operations at Eli Lilly & Co (LLY), reported transactions involving company common stock.
• On February 1, 2026, Hernandez acquired 3,572 shares of common stock at a price of $0, likely through the vesting of restricted stock units.
• Concurrently, 1,591.452 shares of common stock were disposed of at a price of $1,037.15 per share, typically to cover tax obligations related to the vesting.
• Following these transactions, Hernandez directly beneficially owns 41,711.983 shares of common stock.
• Additionally, Hernandez indirectly beneficially owns 871.94 shares of common stock through a 401(k) plan.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, pre-planned insider transaction related to executive compensation and tax obligations, with no immediate positive or negative implications for the company's operational or financial performance.

Positives

• The acquisition of 3,572 shares at $0 indicates the vesting of restricted stock units, a form of equity compensation, which aligns the executive's interests with shareholders.
• The transaction was pre-planned under a Rule 10b5-1(c) contract, suggesting a structured approach to equity management rather than opportunistic trading.

Negatives

• A disposition of 1,591.452 shares occurred, reducing direct beneficial ownership, although this was likely for tax withholding purposes related to the RSU vesting.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those related to equity compensation vesting and tax withholding, are common across the pharmaceutical industry. These transactions typically reflect pre-established compensation plans rather than new strategic shifts or market outlooks.

Related Party Transactions

• The reported transactions involve an executive of Eli Lilly & Co, Edgardo Hernandez, acquiring and disposing of company stock, which constitutes a related party transaction under SEC rules.

Stakeholder Impact

• Shareholders: The transactions represent a routine part of executive compensation, aligning executive interests with shareholder value through equity ownership, though a portion was sold for tax purposes.
• Employees: The vesting of restricted stock units is a common form of long-term incentive compensation for executives, reflecting standard practices in employee retention and motivation.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider transaction related to executive compensation (vesting of restricted stock units and subsequent tax-related sale). It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a catalyst for significant price movement or a re-evaluation of the company's fundamentals.

Keywords

Eli Lilly, LLY, Form 4, Insider Trading, Stock Transaction, Restricted Stock Unit, Equity Compensation, Rule 10b5-1, Executive Compensation